SpectRx, Inc.: New Painless Test for Cervical Cancer Begins Key Segment of FDA Clinical Trial at the University of Miami

MIAMI--(BUSINESS WIRE)--A new non-invasive test for cervical cancer that could potentially eliminate more than three million unnecessary follow up exams to Pap tests is undergoing testing at the Leonard M. Miller School of Medicine at the University of Miami.